1. Academic Validation
  2. Mechanisms of Bushen Tiaoxue Granules against controlled ovarian hyperstimulation-induced abnormal morphology of endometrium based on network pharmacology

Mechanisms of Bushen Tiaoxue Granules against controlled ovarian hyperstimulation-induced abnormal morphology of endometrium based on network pharmacology

  • J Ovarian Res. 2024 Jan 26;17(1):25. doi: 10.1186/s13048-023-01339-3.
Jia-Cheng Zhang # 1 Hao-Lin Zhang # 1 Xi-Yan Xin 1 Yu-Tian Zhu 1 Xin Mao 2 Hang-Qi Hu 1 Yu-Xin Jin 1 Rui-Wen Fan 1 Xiao-Hui Zhang 1 Yang Ye 3 Dong Li 4
Affiliations

Affiliations

  • 1 Department of Traditional Chinese Medicine, Peking University Third Hospital, Beijing, China.
  • 2 Department of Radiology, Peking University Third Hospital, Beijing, China.
  • 3 Department of Traditional Chinese Medicine, Peking University Third Hospital, Beijing, China. [email protected].
  • 4 Department of Traditional Chinese Medicine, Peking University Third Hospital, Beijing, China. [email protected].
  • # Contributed equally.
Abstract

Bushen Tiaoxue Granules (BTG) is an empirical Chinese herbal formula that has been used for the treatment of subfertility. The protective effect of BTG on controlled ovarian hyperstimulation (COH)-induced impaired endometrial receptivity has been reported in our previous study. This study aims to explore the mechanisms of BTG on ameliorating abnormal morphology of endometrium based on network pharmacology. Active compounds of BTG were identified via the traditional Chinese medicine systems pharmacology and UPLC-MS technology. The SwissTargetPrediction platform and HERB database were used to screen out the putative targets of BTG. Potential targets of endometrial dysfunction caused by COH were obtained from three GEO databases. Through the STRING database, the protein-protein interaction was carried out according to the cross-common targets of diseases and drugs. GO terms and KEGG pathways enrichment analyses were conducted via the Metascape database. AutoDock Vina was used for docking validation of the affinity between active compounds and potential targets. Finally, in vivo experiments were used to verify the potential mechanisms derived from network pharmacology study. A total of 141 effective ingredients were obtained from TCMSP and nine of which were verified in UPLC-MS. Six genes were selected through the intersection of 534 disease related genes and 165 drug potential targets. Enrichment analyses showed that BTG might reverse endometrial dysfunction by regulating adherens junction and arachidonic acid metabolism. Hematoxylin-eosin staining revealed that BTG ameliorated the loose and edematous status of endometrial epithelium caused by COH. The protein expression of FOXO1A, β-catenin and COX-2 was decreased in the COH group, and was up-regulated by BTG. BTG significantly alleviates the edema of endometrial epithelium caused by COH. The mechanisms may be related to adheren junctions and activation of arachidonic acid metabolism. The potential active compounds quercetin, taxifolin, kaempferol, eriodictyol, and isorhamnetin identified from the BTG exhibit marginal cytotoxicity. Both high and low concentrations of kaempferol, eriodictyol, and taxifolin are capable of effectively ameliorating impaired hESC cellular activity.

Keywords

Bushen Tiaoxue Granules; Controlled ovarian hyperstimulation; Endometrium; Experimental validation; Morphology; Network pharmacology.

Figures
Products